Key result
Interdisciplinary team care cuts hospitalizations ~45% in metabolic syndrome.
Why the study?
Amidst entrenched disunity in understanding metabolic syndrome formation, this review aimed to identify novel management approaches, demonstrate the need to study distinct phenotypes for early cardiovascular complication prediction, and highlight the role of chronic inflammation in risk assessment.
Does interdisciplinary team-based care and biomarker-guided phenotyping (using hs-CRP and CTI) improve risk stratification and reduce cardiometabolic risk factors and hospitalizations in patients with metabolic syndrome?
Does interdisciplinary team-based care and biomarker-guided phenotyping (using hs-CRP and CTI) improve risk stratification and reduce cardiometabolic risk factors and hospitalizations in patients with metabolic syndrome?
Answers are grounded in this paper and cite their sources.
Phenotyping metabolic syndrome and utilizing inflammatory biomarkers (hs-CRP, CTI) alongside interdisciplinary team-based care substantially reduces hospitalizations and improves cardiometabolic risk factor control.
Purpose: To identify novel approaches to the management of patients with metabolic syndrome (MS), to demonstrate the necessity of studying distinct disease phenotypes for the early prediction of future cardiovascular complications, and to highlight the role of chronic inflammation as an additional marker of elevated risk. Material and methods: An analytical review of contemporary scientific literature (2020–2026) and current clinical practice guidelines was conducted. Data from major cohort studies (Kailuan, REGARDS, Cardiometabolic Center Alliance) were analyzed to evaluate the efficacy of interdisciplinary care models and the utility of high-sensitivity C-reactive protein (hs-CRP) and the C-reactive protein-triglyceride glucose index (CTI) in risk stratification. Consensus documents from the Russian Society of Cardiology (2026) and the American College of Cardiology (2025) were also examined. Results: The prevalence of MS in the Russian Federation was found to range from 6.9% in individuals aged 25–34 to 45.2% in those aged 55–64. The traditional management model was deemed suboptimal due to the lack of unified protocols and the risk of polypharmacy. Interdisciplinary team-based care (MDT) demonstrated high efficacy, achieving a 7.1% reduction in body weight, a 15.1% decrease in HbA1c levels, and a 45% reduction in hospitalization rates (from 1.1±0.4 to 0.6±0.1). In 2026, hs-CRP was incorporated into the diagnostic criteria for cardio-reno-metabolic syndrome (CRMS) in Russia, though the absence of standardized thresholds limits its clinical application. Elevated hs-CRP levels exceeding 3 mg/L were associated with a two-fold increase in cardiovascular event risk. Phenotyping MS (based on combinations of obesity, hypertension, hyperuricemia, and renal dysfunction) enables the prediction of 10-year cardiovascular risk ranging from 0.9% to 51.6% depending on the CRMS stage. The CTI index has been recognized as a promising biomarker for identifying patients requiring intensified surveillance. The implementation of multidisciplinary models in the United States and Europe confirmed a sustained reduction in all major risk factors (LDL-C, blood pressure, and glucose) over a 4-year follow-up period. Conclusion: Phenotyping metabolic syndrome provides a framework for predicting individual cardiovascular risk trajectories. “High-risk” phenotypes necessitate the initiation of intensive pharmacotherapy at early disease stages. Alongside standard treatment protocols, the development of effective anti-inflammatory strategies remains a critical priority to mitigate residual cardiovascular risk in these patients.
No takes yet. Share an insight, caveat, or question.
Yanina et al. (2026) conducted a review in Metabolic syndrome (MS) and cardio-reno-metabolic syndrome (CRMS). Interdisciplinary team-based care (MDT) and disease phenotyping with hs-CRP/CTI risk stratification vs. Traditional management model was evaluated on Body weight, HbA1c levels, hospitalization rates, and 10-year cardiovascular event risk. Interdisciplinary team-based care reduced body weight by 7.1%, HbA1c by 15.1%, and hospitalizations by 45% in metabolic syndrome patients.
Synapse has enriched 10 related papers. Consider them for comparative context: